Micron Technology Inc (0R2T)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 917.50 |
|---|---|
| 52-week range | 191.80 – 1,254.61 |
| Return, 1 month / 3 months | −8.4% / +3.8% |
| Return, 1 year / 3 years | +379.6% / +1,269.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 80.0% |
| Worst drawdown (1 year) | -37.2% |
| Average daily value traded | 114.06M USD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Micron Technology is a semiconductor company that designs and manufactures memory and storage products. Its main offerings are dynamic random access memory chips and flash memory, which are used in computers, servers, smartphones, and other electronic devices. The company also sells memory upgrades and storage products directly to consumers under its own brand. Micron Technology is based in Boise, Idaho, in the United States, and serves device makers and data centre operators around the world.
The shares are listed on the London Exchange in UK under the code 0R2T, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Micron Technology Inc (0R2T) trades on the London Exchange in UK. It last closed at USD 917.50 on 19 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 884 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 379.6% and over the last three months it rose 3.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.8% | ||
| From 52-week high | -25.5% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.8% | ||
| 6-month return | 104.5% | ||
| 12-month return, skipping the last month | 423.5% | ||
| Stability (higher is calmer) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 80.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.2% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 114.06M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −7.5% |
|---|---|
| 1 month | −8.4% |
| 3 months | +3.8% |
| 6 months | +104.5% |
| 1 year | +379.6% |
| 3 years | +1,269.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 980.61 / 723.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 46.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Oct 2026 | USD 0.1500 |
| 6 Jul 2026 | USD 0.1500 |
| 30 Mar 2026 | USD 0.1500 |
| 29 Dec 2025 | USD 0.1150 |
| 3 Oct 2025 | USD 0.1150 |
| 7 Jul 2025 | USD 0.1150 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.